期刊文献+

β受体阻滞剂在右心衰应用中的临床疗效分析

Clinical efficacy of β-blockers in treatment of right heart failure
下载PDF
导出
摘要 目的对β受体阻滞剂在右心衰应用中的临床疗效进行分析。方法将我院2013年3月~2013年12月接诊的56例右心衰患者作为研究对象,随机将患者分为对照组与观察组。对照组患者接受常规治疗,观察组患者在常规治疗的基础上静脉注射β受体阻滞剂。观察记录两组患者治疗期间,临床症状、体征改善情况。结果对照组治疗总有效率为67.9%(19/28),观察组治疗总有效率为92.9%(26/28),两组对比差异显著(P〈0.05),具有统计学意义。结论β受体阻滞剂用于治疗右心衰能有效改善治疗效果,提高患者生存质量,适合于临床推广应用。 Objective To analyze the clinical efficacy of β-blockers in treating right heart failure. Methods Study subjects included 56 patients with right heart failure who were admitted to our hospital between March 2013 and December 2013. The patients were randomly divided into control group and observation group. Patients in the control group received conventional therapy, while those in the observation group received intravenous β-blockers in addition to the conventional therapy. Improvements in clinical symptoms and signs of the patients in both groups were observed and recorded. Results The overall response rate in the observation group was 92.9% (26/28), which was significantly higher than 67.9% (19/28) in the control group (P〈0.05). Conclusion β-blockers can effectively treat right heart failure and improve patients" quality of life.
作者 李华萍
出处 《心血管病防治知识(学术版)》 2015年第5期83-85,共3页 Prevention and Treatment of Cardiovascular Disease
关键词 Β受体阻滞剂 右心衰 临床疗效 β-Blocker Right heart failure Clinical efficacy
  • 引文网络
  • 相关文献

参考文献5

二级参考文献36

共引文献38

;
使用帮助 返回顶部